The Valley Desk

NCT03474965 · Interventional trial

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

Overall registry status Completed

Phase 2

Conditions Sickle Cell Disease (SCD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov